Stocks · Health care · Pharmaceutical Preparations

Lilly (Eli)

LLY Clue Score72
United States Fiscal year ends December CIK 0000059478 Results filed 29 Oct 2026

What the insiders did Net selling

By person

57 insiders · 1,459 transactions
471×

David A. Ricks holds 471 times base salary in stock. $801.84M of shares against $1.70M in salary for 2025.

Salary from the company's own proxy. The shares are what David A. Ricks last reported holding, valued at $1,402.52, the price Common Stock was last bought or sold at on the open market here, on 2 Nov 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Lilly Endowment Inc entity
Former 10% Shareholder
—
$12.27B (1334)
−$12.27B
91,881,150
9.76%
$128.87B
−27.0%
Alfonso G Zulueta
SVP & President, Lilly Int'l
—
$14.21M (15)
−$14.21M
56,947
0.0060%
$79.87M
+29.7%
Anat Hakim
EVP, GC & Secretary
—
$12.96M (2) scheduled
−$12.96M
57,437
0.0061%
$80.56M
+29.2%
Donald A Zakrowski
SVP, Finance, & CAO
—
$12.22M (26) scheduled
−$12.22M
3,163
0.0003%
$4.44M
−29.6%
Patrik Jonsson
EVP & President, LLY Int'l
—
$10.57M (4) scheduled
−$10.57M
54,147
0.0058%
$75.94M
+179.4%
Myles O'Neill
SVP & Pres., Mfg. Operations
—
$9.33M (4)
−$9.33M
81,002
0.0086%
$113.61M
−13.9%
Johna Norton
EVP, Global Quality
—
$7.87M (4) scheduled
−$7.87M
25,556
0.0027%
$35.84M
+80.7%
Enrique A Conterno
SVP&Pres, LillyDiab & LillyUSA
—
$7.22M (3)
−$7.22M
132,962
0.0141%
$186.48M
+17.1%
Susan Mahony
SVP & Pres., Lilly Oncology
—
$6.43M (5)
−$6.43M
43,145
0.0046%
$60.51M
−48.6%
Stephen F Fry
SVP, HR & Diversity
—
$5.97M (7)
−$5.97M
152,631
0.0162%
$214.07M
+165.1%
Ilya Yuffa
EVP&Pres, LLY USA&Global Capab
—
$5.08M (5) scheduled
−$5.08M
29,804
0.0032%
$41.80M
+337.5%
Michael J Harrington
Senior VP and General Counsel
—
$3.69M (2)
−$3.69M
169,800
0.0180%
$238.15M
+43.0%
Jeffrey N Simmons
SVP&Pres. Elanco Animal Health
—
$2.57M (3)
−$2.57M
135,458
0.0144%
$189.98M
+22.1%
Daniel Skovronsky
EVP, CS&PO & Pres. LRL
$2.04M (3)
$4.32M (3)
−$2.28M
235,569
0.0250%
$330.39M
+363.6%
Melissa S Barnes
Chief Eth/Cmpl Ofcr & SVP, ERM
—
$1.67M (4)
−$1.67M
34,616
0.0037%
$48.55M
+618.0%
Anne E. White
EVP & Pres, Lilly Neuroscience
$108.84K (1)
$1.72M (2)
−$1.61M
74,210
0.0079%
$104.08M
+672.8%
Christi Shaw
SVP and Pres., Lilly Bio-Meds
—
$1.58M (3)
−$1.58M
0
0.0000%
$0.00
—
David A Ricks
President, Chair, and CEO
$1.55M (2)
—
+$1.55M
685,273
0.0728%
$961.11M
+1,235%
Alonzo Weems
EVP, Erm & Ceco
—
$1.41M (4)
−$1.41M
7,951
0.0008%
$11.15M
+57.1%
J Erik Fyrwald
Director
$1.01M (2)
—
+$1.01M
75,544
0.0080%
$105.95M
+21.9%
Jackson P Tai
Director
$955.66K (6)
—
+$955.66K
63,524
0.0067%
$89.09M
+37.7%
Derica W Rice
EVP-Global Services and CFO
—
$861.09K (2)
−$861.09K
38,292
0.0041%
$53.71M
—
Naarden Jacob Van
EVP,Pres LLY Oncology&HdCorpBD
$647.36K (1)
—
+$647.36K
26,626
0.0028%
$37.34M
+621.2%
Aarti S. Shah
SVP & Cido
—
$526.53K (2)
−$526.53K
31,622
0.0034%
$44.35M
+235.8%
Ralph Alvarez
Director
$500.47K (1)
—
+$500.47K
57,364
0.0061%
$80.45M
+43.3%
Lucas Montarce
EVP & CFO
$494.63K (1)
—
+$494.63K
17,191
0.0018%
$24.11M
+64.2%
Jamere Jackson
Director
$127.91K (1)
—
+$127.91K
9,635
0.0010%
$13.51M
+1,335%
Gabrielle Sulzberger
Director
$75.02K (1)
—
+$75.02K
3,016
0.0003%
$4.23M
+3,871%
Joshua L Smiley
Former Officer
$170.30K (3)
$237.60K (1)
−$67.30K
77,659
0.0082%
$108.92M
+390.6%
Marschall S Runge
Director
$49.85K (1)
—
+$49.85K
16,593
0.0018%
$23.27M
+152.2%
R David Hoover
Director
$35.93K (1)
—
+$35.93K
37,784
0.0040%
$52.99M
+13.6%
John C Lechleiter
former director
—
—
—
872,321
0.0927%
$1.22B
+13.9%
Jan M Lundberg
EVP,Science&Tech and Pres. LRL
—
—
—
198,126
0.0210%
$277.88M
+72.7%
Maria A Crowe
President, Mfg. Operations
—
—
—
113,581
0.0121%
$159.30M
+22.8%
Barton R Peterson
Sr. VP, Corp. Affairs & Comm.
—
—
—
108,312
0.0115%
$151.91M
+15.0%
Fionnuala M Walsh
SVP, Global Quality
—
—
—
107,334
0.0114%
$150.54M
+23.0%
Kathi P Seifert
Director
—
—
—
77,038
0.0082%
$108.05M
+12.1%
Franklyn G Prendergast
Director
—
—
—
68,574
0.0073%
$96.18M
+4.4%
Ellen R Marram
Director
—
—
—
56,645
0.0060%
$79.45M
+11.7%
Edgardo Hernandez
EVP & Pres., Mfg. Operations
—
—
—
48,364
0.0051%
$67.83M
+201.3%
Michael L Eskew
Director
—
—
—
45,080
0.0048%
$63.23M
+24.9%
Anat Ashkenazi
EVP & CFO
—
—
—
42,330
0.0045%
$59.37M
+139.2%
Michael B Mason
EVP & Pres., Lilly Diabetes
—
—
—
39,284
0.0042%
$55.10M
+324.7%
Leigh Ann Pusey
EVP, Corp. Affairs & Comm.
—
—
—
31,641
0.0034%
$44.38M
—
Diogo Rau
EVP & Cido
—
—
—
26,230
0.0028%
$36.79M
—
Katherine Baicker
Director
—
—
—
23,503
0.0025%
$32.96M
+78.4%
William G Kaelin Jr
Director
—
—
—
21,837
0.0023%
$30.63M
+89.8%
Juan R Luciano
Director
—
—
—
16,970
0.0018%
$23.80M
+1,186%
Eric Dozier
EVP, Chief People Officer
—
—
—
15,933
0.0017%
$22.35M
+253.0%
Kenneth L. Custer
EVP & President, Card Met Hlth
—
—
—
11,935
0.0013%
$16.74M
+27.4%
Adrienne S Brown
EVP, President LLY Imm
—
—
—
9,894
0.0011%
$13.88M
+40.4%
Karen Walker
Director
—
—
—
6,249
0.0007%
$8.76M
+2,282%
Carolyn R Bertozzi
Director
—
—
—
6,243
0.0007%
$8.76M
+3,186%
Kimberly H Johnson
Director
—
—
—
3,265
0.0003%
$4.58M
+4,186%
Mary Lynne Hedley
Director
—
—
—
2,253
0.0002%
$3.16M
+721.5%
Melissa Seymour
EVP, Global Quality
—
—
—
1,038
0.0001%
$1.46M
—
Jon R Moeller
Director
—
—
—
304
<0.0001%
$426.75K
+328.6%